Survival in COPD patients with hospitalization due to exacerbation

M. J. Rodriguez Guzman, I. Fernandez Ormaechea, L. Alvarez Suarez, M. T. Perez Warnisher, R. Martinez Carranza, G. Peces-Barba, F. Villar Alvarez (Madrid, Spain)

Source: International Congress 2014 – Longitudinal studies of respiratory disease
Session: Longitudinal studies of respiratory disease
Session type: Poster Discussion
Number: 2978
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Background / ObjectivesThe increase in the number of exacerbations and comorbidities in COPD carries a worse prognosis and survival. The new GOLD 2014 classification includes patients with one hospital exacerbation in the C and D groups. Our goal was to observe in a cohort of COPD patients, the overall survival and relate it with the number of exacerbations and associated comorbidity.MethodsRetrospective, observational study of COPD patients, hospitalized with at least one exacerbation in 2009. Subsequently we followed to determine overall survival at 3 years and related to the number of exacerbations, comorbidity measured by the Charlson index, the new 2014 GOLD and phenotype classification by GesEPOC guide.Results212 patients, 77.8 % men and 22.2% women were studied, mean age of 73.32 + 9.98 years, mean FEV1 of 48.68 + 16.85%, number of exacerbations average of 1.94 + 1.31, the mean value of 2.3 + mMRC scale and index 0.9 Average Charlson 5.84 + 2.02. At follow-up, 89 patients died. Median survival could not be calculated because follow up finished with a cummulative survival greater than 50 %. The age-adjusted survival was lower in exacerbator phenotypes (C and D ) of the GesEPOC (HR 2.142, CI 95 % 1390-3303 , p : 0.0004 ). The risk of mortality in patients with Charlson index > 5 is 72.1 % ( HR: 1.721 , CI: 1077-2749, p : 0.0184 ). Finally, our patients with > 2 exacerbations in a year, have a 84 % risk of death ( HR: 1.841 , CI 95 % 1205-2812 , p : 0.0044)ConclusionsIn our population of patients hospitalized for at least one exacerbation COPD, survival decreased in patients with more exacerbations and comorbidity measured by the Charlson index and was lower in exacerbator phenotypes of the GesEPOC.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. J. Rodriguez Guzman, I. Fernandez Ormaechea, L. Alvarez Suarez, M. T. Perez Warnisher, R. Martinez Carranza, G. Peces-Barba, F. Villar Alvarez (Madrid, Spain). Survival in COPD patients with hospitalization due to exacerbation. Eur Respir J 2014; 44: Suppl. 58, 2978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015

One-year mortality in COPD patients after severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015

The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Mortality and readmissions in patients with severe COPD. Validation of the CODEX index
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015


Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016


Vitamin D, exacerbations and hospitalizations in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013

Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


RT protocol reduces AECOPD readmissions
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016